Abstract. Gastric cancer is one of the most common malignant tumors and one of the leading causes of cancer-related mortality. Recent studies have revealed that there is a difference in microRNA (miR/miRNA) profiles between cancerous and normal tissues. To find a potentially useful prognostic predictor and a promising therapeutic tool for gastric cancer, the present study investigated the expression and clinical significance of the miR-200 family in gastric cancer. The miR-200 family has five members: hsa-miR-200a, hsa-miR-200b, hsa-miR-200c, hsa-miR-141 and hsa-miR-429. In 46 clinical samples of gastric cancer and paired non-cancerous tissues, the present study observed that the expression levels of the miR-200 family in the cancer tissues were significantly lower than those in the non-cancerous tissues (P<0.001). Lower levels of the five family members were associated with histological grade and the presence of an intravascular cancer embolus (P<0.05). The results revealed that the miR-200 family is downregulated in gastric cancer, and that there are significant differences in the expression of the miR-200 family between normal and cancer tissues. The miR-200 family may therefore become a potentially useful prognostic predictor of the aggressiveness of gastric cancer and a possible therapeutic tool in affected patients.
Introduction
Gastric cancer is one of the most common malignant tumors and one of the primary causes of cancer-related mortality in China. This is mainly a result of patients being diagnosed late and the consequently low surgical resection rate (1) (2) (3) . An improved understanding of the pathogenesis and pathological characteristics of gastric cancer will provide a novel method to ensure an early diagnosis and treatment.
microRNAs (miR/miRNAs) are a class of small and highly conserved non-coding RNA, which regulate gene expression by binding to the 3' untranslated region (3'UTR) of target mRNAs. Growing evidence indicates that miRNAs play a key role in cancer development, differentiation and progression, acting as tumor oncogenes or suppressors (4) (5) (6) . Notably, miR-200 family is downregulated in certain types of cancer, such as hepatocellular carcinoma and renal cell carcinoma, while being overexpressed in others, including melanoma, and ovarian and bladder cancer (7) (8) (9) .
In the present study, in order to identify the changes in expression of miR-200 in normal and cancer tissues, the expression of the miR-200 family was examined in cancerous and paired non-cancerous tissues by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and the distinguishing characteristics of the five members of the miR-200 family were analyzed. Positive results from this study may serve as the foundation for a novel prognostic predictor of grading and a possible therapeutic tool for gastric cancer.
Materials and methods

Human tissue samples.
A total of 46 fresh tissue samples, consisting of gastric cancer tissues and paired normal tissues (5 cm away from the tumor), were obtained from surgical resection specimens collected by the Fourth Hospital of Hebei Medical University (Shijiazhuang, Hebei, China) between 2010 and 2011. The tissues were collected and used after obtaining informed consent from the patients. All tissue samples were immediately cut and snap frozen in liquid nitrogen until RNA extraction. Histological typing of the tumor and paired non-cancerous tissues was pathologically confirmed. This study was approved by the ethics committee of the Fourth Hospital of Hebei Medical University.
RT-qPCR. Total RNA, including miRNA, was extracted from the tissues using the miRNeasy Mini kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer's instructions. Total RNA was subsequently reverse transcribed to 
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Co., Ltd., Dalian, China). The reactions were placed in a 96-well plate (Applied Biosystems Life Technologies, Foster City, CA, USA) using a preheated real-time instrument (ABI 7500HT; Applied Biosystems Life Technologies). The relative levels of expression were quantified and analyzed using Bio-Rad iCycler iQ software (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Ct values were used to calculate the RNA expression levels. The amount of target gene expression (2 -∆∆ Ct) was normalized using the endogenous U6 reference.
Statistical analysis. Data are presented as the median ± standard deviation, unless otherwise stated. All statistical tests were two-sided, and a value of P<0.05 was considered to indicate a statistically significant difference. Student's t-test and a one-way analysis of variance (ANOVA) were employed to analyze the differences among groups and comparisons between two groups using Statistical Analysis System V8 software (SAS Institute Inc., Cary, NC, USA).
Results
Expression of the miR-200 family in gastric cancer tissues.
To expression between the cancerous and normal tissues was similar.
Correlation with histoclinical data. To determine whether the downregulation of the expression of the miR-200 family in gastric cancer tissues was correlated with clinicopathological characteristics, an ANOVA was performed. The median of the relative expression values and the clinicopathological factors are presented in Tables II-VI . The statistical analysis showed that the expression levels of the five family members were associated with histological grade and the presence of an intravascular cancer embolus (P<0.05). The expression level of the family was downregulated in G3 grade gastric cancer compared with G2 grade. In the gastric cancer tissues, the expression level of the miR-200 family was decreased when an intravascular cancer embolus was present. However, no 
Discussion
Numerous miRNAs have been suggested to play vital roles in gastric cancer development and progression, functioning in a either a cooperative manner or alone (10) (11) (12) . An independent study by Kogo et al reported that miR-146a levels were dramatically decreased in gastric cancer, and more importantly, lower levels of miR-146a were associated with lymph node metastasis and venous invasion (13) . The expression of let-7f has also been proven to be decreased in metastatic gastric cancer tissues, while let-7f overexpression in gastric cancer was able to inhibit the invasion and migration of gastric cancer cells (14) . Another study demonstrated the significant downregulation of miR-148b in 106 gastric cancer tissues and the consequent suppression of gastric cancer cell growth, suggesting that miR-148b could become a potential biomarker and therapeutic target against gastric cancer (15) . (16) (17) (18) (19) . Notably, the expression of the miR-200 family can be downregulated or upregulated in different types of cancers, and the tissue of origin may account for this. One study clearly showed that the expression of miRNA-141 and miRNA-200c was significantly decreased in renal cell carcinoma samples (20) . However, a number of studies have shown that the miR-200 family is overexpressed in bladder, ovarian and cervical cancer. Together, these data suggest that the miR-200 family may play multiple roles in potentially regulating tumor initiation and progression (21, 22) . In the present study, the expression and clinical significance of the miR-200 family in gastric cancer was analyzed using a standardized qPCR approach. The results highlight the significance of the miR-200 family as a promising tumor suppressor in gastric cancer. It was shown that the miR-200 family is frequently downregulated in gastric cancer tissues compared with matched non-cancerous tissues. Furthermore, low miR-200 family expression levels were also shown to correlate with histological grade and the presence of an intravascular cancer embolus.
In summary, the present comprehensive analysis showed that the expression of the miR-200 family has a correlation with the development of gastric cancer. Additionally, we found that lower levels of the five family menbers of the miR-200 family were associated with the clinical significance of gastric cancer. These results suggest that the miR-200 family can serve as a new prognostic predictor of the aggressiveness of gastric cancer and as a possible therapeutic tool for affected patients.
